![Dr. Sami Taneja](/news/sites/default/files/styles/hero/public/2019-08/inthemedia-screening-and-treatment-options-prostate-cancer-dr-samir-taneja_0.jpg?h=cf9e043c&itok=tixuF9_2)
Dr. Samir Taneja, director of the Division of Urologic Oncology and co-director of 秘密研究所 Langone鈥檚 Smilow Comprehensive Prostate Cancer Center.
Photo: Jonathan Kozowyk
Around 70 percent of men over age 70 have at least some cancerous cells in their prostate; however, only 11.6 percent of men ever receive a prostate cancer diagnosis. Back in the 1990s, the approach was to screen all men and intervene in all diagnosed cases, although prostate cancer is often slow-growing and asymptomatic.
鈥淲e failed to recognize that there were a lot of cancers we were treating that didn鈥檛 have the potential to harm the patient,鈥 Samir Taneja, MD, director of the and co-director of 秘密研究所 Langone鈥檚 Smilow Comprehensive Prostate Cancer Center, tells Esquire. 鈥淒octors were ripping up the lawn to pull out the weeds.鈥
Times have changed. Those who have a family history, are African American, have cancer-causing genetic mutations, or are over 55 are known to be at higher risk for prostate cancer. There are many options for screening and treating a detected prostate cancer, including the active surveillance approach for early stage cancers in lower-risk groups.
Read more from .